REFERENCES
- Ford J.L. The Current Status of Solid Dispersions. Pharm. Acta Helv. 1986; 61: 69–88
- Chiou W.L., Riegalman S. Pharmaceutical Applications of Solid Dispersion Systems. J. Pharm. Sci. 1971; 60: 1281–1302
- Serajuddin A.T.M. Solid Dispersions of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
- Leuner C., Dressman J. Improving Drug Solubility for Oral Delivery Using Solid Dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
- Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K. Improvement of Dissolution Characteristics and Bioavailability of Poorly Water-Soluble Drugs by Novel Cogrinding Method Using Water-Soluble Polymer. Int. J. Pharm. 1998; 160: 11–19
- Pozzi F., Longo A., Lazzarini C., Carenzi A. Formulations of Ubidecarenone with Improved Bioavailability. Eur. J. Pharm. Biopharm. 1991; 37: 243–246
- Sheen P.C., Khetarpal V.K., Cariola C.M., Rowlings C.E. Formulation Studies of a Poorly Water-Soluble Drug in Solid Dispersions to Improve Bioavailability. Int. J. Pharm. 1995; 18: 221–227
- Sheen P.C., Kim S.I., Petillo J.J., Serajuddin A.T.M. Bioavailability of a Poorly Water-Soluble Drug from Tablet and Solid Dispersion in Humans. J. Pharm. Sci. 1991; 80: 712–714
- Damian F., Blaton N., Naesens L., Balzarini J., Kinget R., Augustijns P., Van den Mooter G. Physicochemical Characterization of Solid Dispersions of the Antiviral Agent UC 781 with Polyethylene Glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 2000; 10: 311–322
- Dordunoo S.K., Ford J.L., Rubinstein M.H. Solidification Studies of Polyethylene Glycols, Gelucire 44/14 or Their Dispersions with Triamterene or Temazepam. J. Pharm. Pharmacol. 1996; 48: 782–789
- , Company literature on Neusilin, Fuji Chemical Industry Co. Ltd., Toyama, Japan.
- Carr R.L. Evaluating Flow Properties of Solids. Chem. Eng. 1965; 72: 163–168